Literature DB >> 20463750

Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution.

E Kostareli1, L-A Sutton, A Hadzidimitriou, N Darzentas, A Kouvatsi, A Tsaftaris, A Anagnostopoulos, R Rosenquist, K Stamatopoulos.   

Abstract

The study of intraclonal diversification (ID) in immunoglobulin (IG) genes offers valuable insight into the role of ongoing interactions with antigen in lymphomagenesis. We recently showed that ID in the IG heavy chain genes of patients with chronic lymphocytic leukemia (CLL) was generally limited; however, intense ID was evident in selected cases, especially those expressing stereotyped IGHV4-34 rearrangements and assigned to subset 4. Here, we report results from a large-scale subcloning study of IG light variable genes, in a total of 1008 subcloned sequences from 56 CLL cases. Multiple analogies were noted between heavy and light chains regarding the occurrence and molecular features of ID. More specifically, the impact of ID on the clonotypic light chains was generally low, with the significant exception of subset 4. Similar to the IGHV4-34 heavy chains of this subset, their partner IGKV2-30 light chains were affected by an active and precisely targeted ID process. Altogether, these findings strengthen the argument that stereotypy in subset 4 extends to stereotyped ID patterns for both heavy and light chains through persistent antigenic stimulation. Furthermore, they strongly suggest that light chains have an active role in the antigen selection process, at least for certain subsets of CLL cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463750     DOI: 10.1038/leu.2010.90

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  17 in total

1.  Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.

Authors:  Millaray Marincevic; Mahmoud Mansouri; Meena Kanduri; Anders Isaksson; Hanna Göransson; Karin Ekström Smedby; Jesper Jurlander; Gunnar Juliusson; Fred Davi; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

2.  Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements.

Authors:  A Vardi; E Vlachonikola; M Karypidou; E Stalika; V Bikos; K Gemenetzi; C Maramis; A Siorenta; A Anagnostopoulos; S Pospisilova; N Maglaveras; I Chouvarda; K Stamatopoulos; A Hadzidimitriou
Journal:  Leukemia       Date:  2016-11-25       Impact factor: 11.528

3.  Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders.

Authors:  Ana Henriques; Arancha Rodríguez-Caballero; Ignacio Criado; Anton W Langerak; Wendy G Nieto; Quentin Lécrevisse; Marcos González; Emília Cortesão; Artur Paiva; Julia Almeida; Alberto Orfao
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

Review 4.  Antigen receptor stereotypy in chronic lymphocytic leukemia.

Authors:  K Stamatopoulos; A Agathangelidis; R Rosenquist; P Ghia
Journal:  Leukemia       Date:  2016-11-04       Impact factor: 11.528

5.  Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.

Authors:  Monica Colombo; Giovanna Cutrona; Daniele Reverberi; Sonia Fabris; Antonino Neri; Marina Fabbi; Giovanni Quintana; Giovanni Quarta; Fabio Ghiotto; Franco Fais; Manlio Ferrarini
Journal:  Mol Med       Date:  2011-04-28       Impact factor: 6.354

6.  An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4.

Authors:  Lesley-Ann Sutton; Giorgos Papadopoulos; Anastasia Hadzidimitriou; Stavros Papadopoulos; Efterpi Kostareli; Richard Rosenquist; Dimitrios Tzovaras; Kostas Stamatopoulos
Journal:  Mol Med       Date:  2015-04-02       Impact factor: 6.354

7.  Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

Authors:  Meena Kanduri; Millaray Marincevic; Anna M Halldórsdóttir; Larry Mansouri; Katarina Junevik; Stavroula Ntoufa; Hanna Göransson Kultima; Anders Isaksson; Gunnar Juliusson; Per-Ola Andersson; Hans Ehrencrona; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Epigenetics       Date:  2012-11-15       Impact factor: 4.528

8.  Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.

Authors:  Ann-Charlotte Bergh; Chamilly Evaldsson; Lone Bredo Pedersen; Christian Geisler; Kostas Stamatopoulos; Richard Rosenquist; Anders Rosén
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

9.  Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.

Authors:  Shih-Shih Chen; Franak Batliwalla; Nichol E Holodick; Xiao-Jie Yan; Sophia Yancopoulos; Carlo M Croce; Thomas L Rothstein; Nicholas Chiorazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

10.  Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence.

Authors:  Lesley-Ann Sutton; Efterpi Kostareli; Evangelia Stalika; Athanasios Tsaftaris; Achilles Anagnostopoulos; Nikos Darzentas; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Mol Med       Date:  2013-08-28       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.